Institute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy (M. Pagnesi, D.G., E.V., M.A., C.M.L., R.M.I., D.T., M. Metra).
Humanitas Research Hospital IRCCS, Rozzano-Milan, Italy (M.C., F.L., M. Maccallini, A.V., G.G., M. Montella, D.P.).
Circ Heart Fail. 2023 Dec;16(12):e011003. doi: 10.1161/CIRCHEARTFAILURE.123.011003. Epub 2023 Nov 1.
The "I Need Help" markers have been proposed to identify patients with advanced heart failure (HF). We evaluated the prognostic impact of these markers on clinical outcomes in a real-world, contemporary, multicenter HF population.
We included consecutive patients with HF and at least 1 high-risk "I Need Help" marker from 4 centers. The impact of the cumulative number of "I Need Help" criteria and that of each individual "I Need Help" criterion was evaluated. The primary end point was the composite of all-cause mortality or first HF hospitalization.
Among 1149 patients enrolled, the majority had 2 (30.9%) or 3 (22.6%) "I Need Help" criteria. A higher cumulative number of "I Need Help" criteria was independently associated with a higher risk of the primary end point (adjusted hazard ratio for each criterion increase, 1.19 [95% CI, 1.11-1.27]; <0.001), and patients with >5 criteria had the worst prognosis. Need of inotropes, persistently high New York Heart Association classes III and IV or natriuretic peptides, end-organ dysfunction, >1 HF hospitalization in the last year, persisting fluid overload or escalating diuretics, and low blood pressure were the individual criteria independently associated with a higher risk of the primary end point.
In our HF population, a higher number of "I Need Help" criteria was associated with a worse prognosis. The individual criteria with an independent impact on mortality or HF hospitalization were need of inotropes, New York Heart Association class or natriuretic peptides, end-organ dysfunction, multiple HF hospitalizations, persisting edema or escalating diuretics, and low blood pressure.
“我需要帮助”标记物被提议用于识别患有晚期心力衰竭(HF)的患者。我们评估了这些标记物在现实世界中、当代、多中心 HF 人群中的临床结局的预后影响。
我们纳入了来自 4 个中心的至少有 1 个高危“我需要帮助”标记物的连续 HF 患者。评估了累积“我需要帮助”标准数量和每个单独“我需要帮助”标准的影响。主要终点是全因死亡率或首次 HF 住院的复合终点。
在纳入的 1149 例患者中,大多数患者有 2 个(30.9%)或 3 个(22.6%)“我需要帮助”标准。累积“我需要帮助”标准数量较高与主要终点风险增加独立相关(每个标准增加的调整后的危险比,1.19 [95%CI,1.11-1.27];<0.001),且具有>5 个标准的患者预后最差。需要正性肌力药、持续存在纽约心脏协会(NYHA)III 级或 IV 级或利钠肽、终末器官功能障碍、过去 1 年中>1 次 HF 住院、持续液体超负荷或利尿剂升级、低血压是与主要终点风险增加独立相关的个别标准。
在我们的 HF 人群中,较高数量的“我需要帮助”标准与预后较差相关。对死亡率或 HF 住院具有独立影响的个别标准是需要正性肌力药、NYHA 分级或利钠肽、终末器官功能障碍、多次 HF 住院、持续水肿或利尿剂升级、低血压。